Ad is loading...
BMEA
Price
$6.53
Change
-$0.58 (-8.16%)
Updated
Nov 15 closing price
105 days until earnings call
COGT
Price
$8.90
Change
-$0.75 (-7.77%)
Updated
Nov 15 closing price
120 days until earnings call
Ad is loading...

BMEA vs COGT

Header iconBMEA vs COGT Comparison
Open Charts BMEA vs COGTBanner chart's image
Biomea Fusion
Price$6.53
Change-$0.58 (-8.16%)
Volume$913.89K
CapitalizationN/A
Cogent Biosciences
Price$8.90
Change-$0.75 (-7.77%)
Volume$1.32M
CapitalizationN/A
BMEA vs COGT Comparison Chart
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BMEA vs. COGT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Sell and COGT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BMEA: $6.53 vs. COGT: $8.90)
Brand notoriety: BMEA and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 111% vs. COGT: 121%
Market capitalization -- BMEA: $236.64M vs. COGT: $983.11M
BMEA [@Biotechnology] is valued at $236.64M. COGT’s [@Biotechnology] market capitalization is $983.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, BMEA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 4 TA indicator(s) are bullish while COGT’s TA Score has 5 bullish TA indicator(s).

  • BMEA’s TA Score: 4 bullish, 6 bearish.
  • COGT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а -20.17% price change this week, while COGT (@Biotechnology) price change was -12.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BMEA is expected to report earnings on Mar 03, 2025.

COGT is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($983M) has a higher market cap than BMEA($237M). COGT YTD gains are higher at: 51.361 vs. BMEA (-55.028). BMEA has higher annual earnings (EBITDA): -149.62M vs. COGT (-240.8M). COGT has more cash in the bank: 363M vs. BMEA (88M). BMEA has less debt than COGT: BMEA (9.57M) vs COGT (18.2M). BMEA (0) and COGT (0) have equivalent revenues.
BMEACOGTBMEA / COGT
Capitalization237M983M24%
EBITDA-149.62M-240.8M62%
Gain YTD-55.02851.361-107%
P/E RatioN/AN/A-
Revenue00-
Total Cash88M363M24%
Total Debt9.57M18.2M53%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEACOGT
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IIGZX12.03-0.02
-0.17%
Voya Global High Dividend Low Vol Port I
GIRVX6.90-0.02
-0.29%
Goldman Sachs Intl Eq Div & Prem Inv
SSCYX6.92-0.08
-1.14%
Saratoga Small Capitalization A
LVORX19.69-0.24
-1.20%
Lord Abbett Value Opportunities R3
CSXAX50.11-0.68
-1.34%
Calvert US Large Cap Core Rspnb Idx A

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-8.16%
ARCT - BMEA
47%
Loosely correlated
-12.65%
ALT - BMEA
33%
Poorly correlated
-9.99%
OCUL - BMEA
32%
Poorly correlated
-7.66%
COGT - BMEA
30%
Poorly correlated
-7.77%
KROS - BMEA
30%
Poorly correlated
-6.18%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-7.77%
SPHDF - COGT
63%
Loosely correlated
N/A
SNDX - COGT
51%
Loosely correlated
-5.72%
KROS - COGT
43%
Loosely correlated
-6.18%
MEOBF - COGT
39%
Loosely correlated
N/A
TNFA - COGT
39%
Loosely correlated
-2.75%
More